Effective early antiretroviral therapy in perinatal-HIV infection reduces subsequent plasma inflammatory profile

[1]  H. Steen,et al.  Determinants of B-Cell Compartment Hyperactivation in European Adolescents Living With Perinatally Acquired HIV-1 After Over 10 Years of Suppressive Therapy , 2022, Frontiers in Immunology.

[2]  Lori A. Coburn,et al.  CCL11 exacerbates colitis and inflammation-associated colon tumorigenesis , 2021, Oncogene.

[3]  O. Levy,et al.  Ontogeny of plasma cytokine and chemokine concentrations across the first week of human life , 2021, Cytokine.

[4]  P. Natarajan,et al.  Clonal hematopoiesis of indeterminate potential (CHIP): Linking somatic mutations, hematopoiesis, chronic inflammation and cardiovascular disease. , 2021, Journal of molecular and cellular cardiology.

[5]  C. Giaquinto,et al.  Early ART initiation during infancy preserves natural killer cells in young European adolescents living with HIV (CARMA cohort) , 2021, Journal of the International AIDS Society.

[6]  S. Gringhuis,et al.  Abortive HIV‐1 RNA induces pro‐IL‐1β maturation via protein kinase PKR and inflammasome activation in humans , 2021, European journal of immunology.

[7]  G. V. Van Zyl,et al.  HIV-1 Persistence in Children during Suppressive ART , 2021, Viruses.

[8]  O. Levy,et al.  Plasma Adenosine Deaminase (ADA)-1 and -2 Demonstrate Robust Ontogeny Across the First Four Months of Human Life , 2021, Frontiers in Immunology.

[9]  C. Giaquinto,et al.  T cell immune discriminants of HIV reservoir size in a pediatric cohort of perinatally infected individuals , 2021, PLoS pathogens.

[10]  A. Castel,et al.  Prevention of Perinatal HIV Transmission in an Area of High HIV Prevalence in the United States. , 2020, The Journal of pediatrics.

[11]  C. Giaquinto,et al.  The CARMA Study: Early Infant Antiretroviral Therapy—Timing Impacts on Total HIV-1 DNA Quantitation 12 Years Later , 2020, Journal of the Pediatric Infectious Diseases Society.

[12]  C. Menéndez,et al.  Association of Maternal Factors and HIV Infection With Innate Cytokine Responses of Delivering Mothers and Newborns in Mozambique , 2020, Frontiers in Microbiology.

[13]  A. Adimora,et al.  Impact of biological sex on immune activation and frequency of the latent HIV reservoir during suppressive antiretroviral therapy. , 2020, The Journal of infectious diseases.

[14]  C. Giaquinto,et al.  Biological Aging and Immune Senescence in Children with Perinatally Acquired HIV , 2020, Journal of immunology research.

[15]  Ryan R Brinkman,et al.  Dynamic molecular changes during the first week of human life follow a robust developmental trajectory , 2019, Nature Communications.

[16]  H. Shang,et al.  IP‐10 is highly involved in HIV infection , 2019, Cytokine.

[17]  P. Palma,et al.  Immune Activation, Inflammation, and Non-AIDS Co-Morbidities in HIV-Infected Patients under Long-Term ART , 2019, Viruses.

[18]  E. Masliah,et al.  Pathogenesis of age-related HIV neurodegeneration , 2019, Journal of NeuroVirology.

[19]  N. Ukibe,et al.  The effects of highly active antiretroviral therapy on the serum levels of pro-inflammatory and anti-inflammatory cytokines in HIV infected subjects , 2018, Journal of biomedical science.

[20]  C. Giaquinto,et al.  Accelerated aging in perinatally HIV-infected children: clinical manifestations and pathogenetic mechanisms , 2018, Aging.

[21]  P. Stenvinkel,et al.  Chronic inflammation in end-stage renal disease and dialysis , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[22]  M. Schetinger,et al.  Adenosine signaling and adenosine deaminase regulation of immune responses: impact on the immunopathogenesis of HIV infection , 2018, Purinergic Signalling.

[23]  Pier Andrea Borea,et al.  Pharmacology of Adenosine Receptors: The State of the Art. , 2018, Physiological reviews.

[24]  I. Meyts,et al.  Deficiency of Adenosine Deaminase 2 (DADA2): Updates on the Phenotype, Genetics, Pathogenesis, and Treatment , 2018, Journal of Clinical Immunology.

[25]  E. Scully.  Sex Differences in HIV Infection , 2018, Current HIV/AIDS Reports.

[26]  J. Leszek,et al.  RAGE-TLR Crosstalk Sustains Chronic Inflammation in Neurodegeneration , 2018, Molecular Neurobiology.

[27]  V. Gotta,et al.  Cytokine profiling in healthy children shows association of age with cytokine concentrations , 2017, Scientific Reports.

[28]  M. Grobusch,et al.  Influence of Age and Other Factors on Cytokine Expression Profiles in Healthy Children—A Systematic Review , 2017, Front. Pediatr..

[29]  L. Ferrucci,et al.  Aging, inflammation and the environment , 2017, Experimental Gerontology.

[30]  S. Mazmanian,et al.  Protecting the Newborn and Young Infant from Infectious Diseases: Lessons from Immune Ontogeny. , 2017, Immunity.

[31]  A. Zavialov,et al.  Human adenosine deaminases ADA1 and ADA2 bind to different subsets of immune cells , 2017, Cellular and Molecular Life Sciences.

[32]  L. Calza,et al.  Significant Decrease in Plasma Levels of D-Dimer, Interleukin-8, and Interleukin-12 After a 12-Month Treatment with Rosuvastatin in HIV-Infected Patients Under Antiretroviral Therapy. , 2016, AIDS research and human retroviruses.

[33]  Ronald Anderson,et al.  Systemic Immune Activation Profiles of HIV-1 Subtype C-Infected Children and Their Mothers , 2016, Mediators of inflammation.

[34]  D. Richman,et al.  Influence of age at virologic control on peripheral blood human immunodeficiency virus reservoir size and serostatus in perinatally infected adolescents. , 2014, JAMA pediatrics.

[35]  M. Altfeld,et al.  Sex-based differences in HIV type 1 pathogenesis. , 2014, The Journal of infectious diseases.

[36]  O. Levy,et al.  Ontogeny of early life immunity. , 2014, Trends in immunology.

[37]  Hinrich W. H. Göhlmann,et al.  Increasing the discovery power of -omics studies , 2013 .

[38]  Yan Luo,et al.  The effect of a year of highly active antiretroviral therapy on immune reconstruction and cytokines in HIV/AIDS patients. , 2013, AIDS research and human retroviruses.

[39]  Ruth R. Montgomery,et al.  Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly. , 2012, Immunity.

[40]  M. Betts,et al.  Cytokine production and dysregulation in HIV pathogenesis: lessons for development of therapeutics and vaccines. , 2012, Cytokine & growth factor reviews.

[41]  Xiaohong Kong,et al.  The role of HIV replicative fitness in perinatal transmission of HIV , 2011, Virologica Sinica.

[42]  N. Glaichenhaus,et al.  Human adenosine deaminase 2 induces differentiation of monocytes into macrophages and stimulates proliferation of T helper cells and macrophages , 2010, Journal of leukocyte biology.

[43]  Ofer Levy,et al.  Innate immunity of the newborn: basic mechanisms and clinical correlates , 2007, Nature Reviews Immunology.

[44]  Anne M Johnson,et al.  Virologic, Immunologic, and Clinical Response to Highly Active Antiretroviral Therapy: the Gender Issue Revisited , 2003, Journal of acquired immune deficiency syndromes.

[45]  D. Boyle,et al.  Adenosine inhibits neutrophil degranulation in activated human whole blood: involvement of adenosine A2 and A3 receptors. , 1997, Journal of immunology.

[46]  G. Trinchieri,et al.  Cytokine patterns during progression to AIDS in children with perinatal HIV infection. , 1995, Journal of immunology.

[47]  K J Rothman,et al.  No Adjustments Are Needed for Multiple Comparisons , 1990, Epidemiology.

[48]  V. Paul,et al.  Perinatal HIV , 2008, Indian journal of pediatrics.

[49]  M. Clerici,et al.  A TH1-->TH2 switch is a critical step in the etiology of HIV infection. , 1993, Immunology today.